her2dx risk-score in early-stage her2-positive breast cancer
Published 1 year ago • 994 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
3:49
her2dx: a new diagnostic tool for early-stage her2 positive breast cancer
-
4:12
optimizing treatment in patients with early-stage her2-positive breast cancer
-
4:26
independent validation of the her2dx genomic test in her2-positive breast cancer
-
1:42
her2dx and pcr in her2-positive breast cancer: a combined analysis of 4 neoadjuvant studies
-
2:13
n9831 trial: genes associated with early and late recurrence in her2 breast cancer
-
4:16
adjuvant treatment for stage i her2 breast cancer
-
1:56
optimizing adjuvant treatment in hr /her2- early breast cancer
-
8:44
reduce the risk of recurrence in early stage her2 breast cancer
-
1:05:11
ask the expert: early-stage her2-positive breast cancer with adrienne waks, md
-
2:05
important considerations in the management of hr , her2-negative early breast cancer
-
0:59
treatment for early stage her2 breast cancer | dana-farber cancer institute
-
3:50
update from kaitlin for high-risk her2-positive early breast cancer
-
2:43
sequencing treatment options in her2 positive breast cancer: 2023 best of breast conference
-
8:21
extended adjuvant therapy for her2-positive breast cancer
-
2:22
cdk4/6 inhibitors in early stage hr /her2- disease
-
1:20
dr tolaney on ongoing clinical trials in early-stage her2 breast cancer
-
1:53
her2 assessment in breast cancer
-
1:29
poziotinib for her2-positive metastatic breast cancer
-
6:46
early-stage her2 breast cancer: the atempt trial